Pharmedic Pharmaceutical Medicinal Joint Stock Company

HNX:PMC Stock Report

Market Cap: ₫1.1t

Pharmedic Pharmaceutical Medicinal Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Tran Trung

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.7yrs
CEO ownershipn/a
Management average tenure5.3yrs
Board average tenure5.7yrs

Recent management updates

Recent updates

CEO

Tran Trung

5.7yrs

Tenure

Mr. Tran Viet Trung serves as a General Manager and Director and served as Chairman at Pharmedic Pharmaceutical Medicinal JSC since April 23, 2019.

Leadership Team

NamePositionTenureCompensationOwnership
Tran Trung
GM & Director5.7yrsno datano data
Le Nguyen
Head of Finance & Chief Accountant2.8yrsno datano data
Phan Phong
Deputy GM & Director5.3yrsno datano data
Tuyen Kim Nguyen
Deputy GM & Director5.3yrsno datano data
Trinh Tra
Deputy General Manager5.3yrsno datano data

5.3yrs

Average Tenure

Experienced Management: PMC's management team is seasoned and experienced (5.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Tran Trung
GM & Director5.7yrsno datano data
Phan Phong
Deputy GM & Director5.7yrsno datano data
Tuyen Kim Nguyen
Deputy GM & Director5.7yrsno datano data
Phim Hoàng
Head of Control Committeeno datano datano data
Hung Le
Chairman5.7yrsno datano data
Cuong Nguyen
Director5.7yrsno datano data
Thang Tran
Director5.7yrsno datano data
Thinh Nguyen
Director5.7yrsno datano data
The Nguyen
Member of Control Board5.7yrsno datano data
Hung Le
Chairman of Control Board1.7yrsno datano data
My Thuy Nguyen
Member of Control Board1.7yrsno datano data

5.7yrs

Average Tenure

Experienced Board: PMC's board of directors are considered experienced (5.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 11:59
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pharmedic Pharmaceutical Medicinal Joint Stock Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution